The latest breast cancer news
The latest breast cancer news
Breast cancer is the most common cancer among women worldwide (WHO, 2023). The Dr. Margarete Fischer-Bosch…
The ESMO Congress 2025 has seen pivotal studies unveiling compelling evidence that a new class of…
Patients with oestrogen-receptor-positive HER-2-negative advanced breast cancer showed significantly improved progression-free survival when treated with…
The National Comprehensive Cancer Network® (NCCN®)—a nonprofit responsible for globally utilised guidelines for cancer care—is sharing…
New research reveals that inflammatory responses may play a role in different types of fatigue…
On September 25, 2025, the Food and Drug Administration approved imlunestrant, an oestrogen receptor antagonist,…
Results from the health-related quality of life (HRQOL) analysis of the University of Pennsylvania and…
Hormone receptor (HR)–positive, ERBB2 (formerly HER2)–negative breast cancer is the most common subtype, accounting for…
A promising new PET tracer can visualise a protein that is commonly overexpressed in triple-negative…
In the post-genomic era, long non-coding RNAs (lncRNAs) have emerged as critical regulators in various…
